Pnc Financial Services Group, Inc. Trevena Inc Transaction History

Pnc Financial Services Group, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.16 - $100.0 $320 - $200,000	2,000 Added 9.09%	24,000 $0
Q2 2022 Aug 12, 2022	BUY	$0.2 - $0.5 $4,400 - $11,000	22,000 New	22,000 $9,000
Q4 2021 Feb 11, 2022	SELL	$0.57 - $1.29 $14,249 - $32,250	-25,000 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$1.11 - $1.7 $5,550 - $8,500	5,000 Added 25.0%	25,000 $30,000
Q2 2021 Aug 06, 2021	BUY	$1.46 - $2.25 $3,650 - $5,625	2,500 Added 14.29%	20,000 $33,000
Q4 2020 Feb 12, 2021	BUY	$2.13 - $3.26 $15,975 - $24,450	7,500 Added 75.0%	17,500 $37,000
Q3 2020 Nov 06, 2020	SELL	$1.53 - $3.13 $7,650 - $15,650	-5,000 Reduced 33.33%	10,000 $29,000
Q2 2019 Aug 09, 2019	BUY	$0.94 - $1.6 $4,700 - $8,000	5,000 Added 50.0%	15,000 $0
Q3 2018 Nov 09, 2018	BUY	$1.39 - $2.25 $12,510 - $20,250	9,000 Added 900.0%	10,000 $0
Q1 2018 May 11, 2018	BUY	$1.51 - $2.06 $1,510 - $2,060	1,000 New	1,000 $0

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $691M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.